"Azalea" love
Release time:
2022-06-21
Summer is approaching, the warmth is rising and flowers are blooming. Red flowers, white flowers, yellow flowers, pink flowers, etc. compete with each other, dotted with everything around, making people feel as if they are in oil painting and enjoying the joy of summer.
A few days ago, I received a phone call from my father. He excitedly asked: "daughter, when will you rest? The mountain opposite the home is full of red this year. People are enjoying the flowers! I 've been sitting on the side of the road these days. There are a lot of people coming and going in that car. " I quickly replied: "Dad, I'll be back from work tomorrow, and when the time comes ..." hung up the phone, looking forward to the arrival of tomorrow.
Dad bombarded me with several phone calls the next afternoon, repeatedly confirming whether to go home. After getting my definite answer, he was as happy as a child at the other end of the phone. Riding a small electric donkey, I walked on the country road, with all kinds of songs in my ears, facing the wind, with bursts of Sophora fragrant in the wind, as if to welcome me home. I saw my father sitting on a roadside bench from afar, looking hard for fear of missing something. I approached him and felt that my father did not recognize me. He let out a cry before he let out a bright smiling face and greeted me in a hurry.
The azalea on the mountain is as prosperous as fire. One point of red, one point of red, one point of red, one point of red. Even the red azalea impacts your visual nerve, making you cannot help admiring the beauty of nature. There is a mysterious force that eliminates your fatigue, makes you forget worldly troubles, and makes you revel in the sea of flowers.
Dad was in poor health and could not climb the mountain with me to enjoy the flowers. There are many tourists at the foot of the mountain. The lively atmosphere makes me feel a little more sad. Dad before becoming a father, is also a yearning for freedom, lively young ah! Although my father was not good at words and failed to give me the life I wanted, he did his best to feed and dress the family. When the silver squeeze away the black hair, dad is no longer the teenager he once was. We can't just take care of ourselves and spend more time with our family members who love us most in our life. (Long Liwei)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31